Emily M. Huebner

1.1k total citations
20 papers, 196 citations indexed

About

Emily M. Huebner is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Emily M. Huebner has authored 20 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Emily M. Huebner's work include Acute Myeloid Leukemia Research (7 papers), Neutropenia and Cancer Infections (4 papers) and Drug-Induced Adverse Reactions (2 papers). Emily M. Huebner is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Neutropenia and Cancer Infections (4 papers) and Drug-Induced Adverse Reactions (2 papers). Emily M. Huebner collaborates with scholars based in United States, Sweden and Australia. Emily M. Huebner's co-authors include Kimberly G. Blumenthal, Anna R. Wolfson, Anna B. Halpern, Kristina M. Adams Waldorf, Roland B. Walter, Elihu H. Estey, Pamela S. Becker, Sarah Buckley, Paul C. Hendrie and Aleena Banerji and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Emily M. Huebner

19 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily M. Huebner United States 8 52 51 35 32 27 20 196
Çiğdem Gereklioğlu Türkiye 8 111 2.1× 57 1.1× 44 1.3× 13 0.4× 13 0.5× 48 285
Vidya Seshan Oman 10 37 0.7× 48 0.9× 72 2.1× 41 1.3× 5 0.2× 40 310
Anna Marie P. Young United States 9 5 0.1× 38 0.7× 34 1.0× 11 0.3× 31 1.1× 27 293
Ornella Di Bella Italy 8 21 0.4× 31 0.6× 8 0.2× 6 0.2× 8 0.3× 16 266
TC Okeke Nigeria 11 22 0.4× 138 2.7× 49 1.4× 40 1.3× 11 0.4× 14 320
Haoyue Cheng China 8 16 0.3× 23 0.5× 15 0.4× 46 1.4× 16 0.6× 29 224
Laura Battisti Italy 7 38 0.7× 20 0.4× 44 1.3× 6 0.2× 7 0.3× 16 157
Gian Carlo Di Renzo Italy 9 17 0.3× 56 1.1× 21 0.6× 102 3.2× 9 0.3× 20 187
Wan‐Ju Wu Taiwan 10 13 0.3× 38 0.7× 19 0.5× 32 1.0× 25 0.9× 33 247
Zijun Liao China 11 18 0.3× 69 1.4× 65 1.9× 37 1.2× 29 1.1× 32 319

Countries citing papers authored by Emily M. Huebner

Since Specialization
Citations

This map shows the geographic impact of Emily M. Huebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Huebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Huebner more than expected).

Fields of papers citing papers by Emily M. Huebner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily M. Huebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Huebner. The network helps show where Emily M. Huebner may publish in the future.

Co-authorship network of co-authors of Emily M. Huebner

This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Huebner. A scholar is included among the top collaborators of Emily M. Huebner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Huebner. Emily M. Huebner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huebner, Emily M., et al.. (2024). Peri-clitoral Epidermal Inclusion Cyst as Initial Presentation of Lichen Sclerosus in a Pediatric Patient. Journal of Pediatric and Adolescent Gynecology. 37(4). 448–450. 1 indexed citations
2.
Lindsay, Julian, Carla S. Walti, Anna B. Halpern, et al.. (2023). Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms. Blood Advances. 7(13). 3140–3145. 3 indexed citations
3.
Coler, Brahm, et al.. (2023). Addressing a broken drug pipeline for preterm birth: why early preterm birth is an orphan disease. American Journal of Obstetrics and Gynecology. 229(6). 647–655. 1 indexed citations
4.
Huebner, Emily M., Anders Elfvin, Brahm Coler, et al.. (2022). Virulence, phenotype and genotype characteristics of invasive group B Streptococcus isolates obtained from Swedish pregnant women and neonates. Annals of Clinical Microbiology and Antimicrobials. 21(1). 43–43. 5 indexed citations
5.
Huebner, Emily M., et al.. (2022). One Vax Two Lives: a social media campaign and research program to address COVID-19 vaccine hesitancy in pregnancy. American Journal of Obstetrics and Gynecology. 227(5). 685–695.e2. 27 indexed citations
6.
Walti, Carla S., Anna B. Halpern, Hu Xie, et al.. (2022). Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia. 37(2). 298–307. 6 indexed citations
7.
Huebner, Emily M., Anders Elfvin, Brahm Coler, et al.. (2022). Virulence Factors of Invasive Group B Streptococcus Isolates Obtained from Pregnant Women and Neonates. American Journal of Obstetrics and Gynecology. 226(2). 300–301. 1 indexed citations
8.
Coler, Brahm, Oksana Shynlova, Stephen J. Lye, et al.. (2021). Landscape of Preterm Birth Therapeutics and a Path Forward. Journal of Clinical Medicine. 10(13). 2912–2912. 26 indexed citations
9.
Banerji, Aleena, Emily M. Huebner, Xiaoqing Fu, et al.. (2020). Perioperative Allergic Reactions: Allergy Assessment and Subsequent Anesthesia. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 1980–1991. 12 indexed citations
10.
Halpern, Anna B., Megan Othus, Emily M. Huebner, et al.. (2020). Interaction of Remission Status and Cause of Death in Acute Myeloid Leukemia. Blood. 136(Supplement 1). 12–13.
11.
McCartney, Stephen A., et al.. (2020). Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19. American Journal of Reproductive Immunology. 84(5). e13320–e13320. 10 indexed citations
12.
Gardner, Kelda M., Anna B. Halpern, Emily M. Huebner, et al.. (2019). Need for routine examination of left ventricular ejection fraction in patients with AML. Leukemia. 34(4). 1169–1171. 2 indexed citations
13.
Blumenthal, Kimberly G., Emily M. Huebner, Aleena Banerji, et al.. (2019). Sex differences in academic rank in allergy/immunology. Journal of Allergy and Clinical Immunology. 144(6). 1697–1702.e1. 18 indexed citations
14.
Wolfson, Anna R., Emily M. Huebner, & Kimberly G. Blumenthal. (2019). Acute care beta-lactam allergy pathways: approaches and outcomes. Annals of Allergy Asthma & Immunology. 123(1). 16–34. 17 indexed citations
16.
Buckley, Sarah, Mary‐Elizabeth M. Percival, Megan Othus, et al.. (2018). A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leukemia & lymphoma. 60(4). 1023–1029. 2 indexed citations
17.
Halpern, Anna B., Megan Othus, Emily M. Huebner, et al.. (2018). Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms. Leukemia. 32(11). 2352–2362. 34 indexed citations
20.
Huebner, Emily M.. (1990). How Continuing Education is Preparing for the 21st Century. The Journal of Continuing Higher Education. 38(2). 9–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026